Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Celyad Oncology SA
  6. News
  7. Official Publications
    CYAD   BE0974260896

CELYAD ONCOLOGY SA

(CYAD)
  Report
Real-time Quote. Real-time Euronext Bruxelles - 05/16 03:00:21 am
1.604 EUR   -2.20%
05/06Celyad Oncology SA Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/05CELYAD ONCOLOGY SA : 1st quarter results
CO
05/05CELYAD ONCOLOGY SA : Proxy Statments
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Official Publications
05/05/22Proxy Statments 
05/05/22Proxy Statments 
05/05/221st quarter results 
05/05/221st quarter results 
04/01/22Ordinary general shareholder meeting 
04/01/22Ordinary general shareholder meeting 
03/24/22SEC Filing 20 F 
03/24/22Annual results 
03/24/22Annual results 
03/24/22Annual Report 
03/24/22Annual Report 
03/24/22Mixed general shareholder meeting 
12/15/21Crossing thresholds 
12/15/21Crossing thresholds 
12/03/21Security operations 
12/03/21Security operations 
11/10/213rd quarter results 
11/10/213rd quarter results 
11/10/21SEC Filing 6K-3 
10/29/21Monthly statement on outstanding equity shares and voting rights 
08/04/21SEC Filing 6K-2 
08/04/21Half-year report 
08/04/21Half-year report 
07/30/21Monthly statement on outstanding equity shares and voting rights 
07/30/21Crossing thresholds 
07/30/21Crossing thresholds 
06/30/21Monthly statement on outstanding equity shares and voting rights 
06/30/21Crossing thresholds 
06/30/21Crossing thresholds 
05/31/21Monthly statement on outstanding equity shares and voting rights 
05/31/21Monthly statement on outstanding equity shares and voting rights 
05/25/21Proxy Statments 
05/19/21Crossing thresholds 
05/19/21Crossing thresholds 
05/07/21SEC Filing 6K-1 
05/06/211st quarter results 
05/06/211st quarter results 
05/05/21Crossing thresholds 
05/05/21Crossing thresholds 
05/05/21Proxy Statments 
05/05/21Proxy Statments 
05/04/21Crossing thresholds 
05/04/21Crossing thresholds 
04/30/21Monthly statement on outstanding equity shares and voting rights 
04/30/21Crossing thresholds 
04/30/21Crossing thresholds 
03/31/21Crossing thresholds 
03/31/21Crossing thresholds 
03/24/21Annual results 
03/24/21Annual Report 
03/24/21Press Release 
03/24/21Annual results 
03/24/21Annual Report 
01/20/21Crossing thresholds 
01/20/21Crossing thresholds 
11/10/203rd quarter earnings 
11/10/203rd quarter earnings 
11/10/203rd quarter earnings 
08/06/20Half-year results 
08/06/20Half-year results 
06/10/20Proxy Statments 
05/07/201st quarter results 
05/07/201st quarter results 
05/07/201st quarter results 
05/05/20Proxy Statments 
05/05/20Proxy Statments 
05/05/20Proxy Statments 
05/05/20Extraordinary general shareholder meeting 
04/03/20Mixed general shareholder meeting 
04/03/20Acquisition 
03/24/20SEC Filing 6K-4 
03/24/20Annual results 
03/24/20Annual results 
03/24/20Annual results 
03/24/20Press Release 
1  2Next
Official Publications
05/051st quarter results 
05/05Proxy Statments 
05/051st quarter results 
05/05Proxy Statments 
04/01Ordinary general shareholder meeting 
04/01Ordinary general shareholder meeting 
Upcoming event on CELYAD ONCOLOGY SA
08/05/22Interim 2022 Earnings Release
Upcoming sector events
07/26/22IQVIA HOLDINGS INC. : Interim 2022 Earnings Release (Projected)
07/27/22LONZA GROUP AG : Interim 2022 Earnings Release (Projected)
07/28/22SEAGEN INC. : Interim 2022 Earnings Release (Projected)
08/10/22MODERNA, INC. : Interim 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research